Aranda - Aranda.org

DEVELOPMENT OF STEWARDSHIP, SURVEILLANCE AND ACCESS STRATEGIES FOR ANTIBIOTICS IN LOW AND MIDDLE INCOME COUNTRIES.
852264092
EIN
2020
Founded
New York City, NY 10128 United States
Address
aranda.org
Web
Description

Aranda Org Inc.

Overview

Aranda Org Inc., identified by its EIN as 852264092, focuses on tackling the global crisis of antimicrobial resistance (AMR). The organization aims to create a sustainable ecosystem for the development and delivery of antimicrobial diagnostics and therapeutics. It operates by building a system that keeps pace with bacterial evolution, ensuring that innovations are connected to patients and innovators receive returns on their investments[3].

Mission and Approach

Aranda's mission is to ensure that antimicrobial diagnostics and therapeutics are developed and delivered appropriately to those in need. It uses a financially solvent and sustainable business model to address the challenges posed by AMR. The model includes a fixed price portfolio for existing and novel antimicrobial consumables and therapeutics, ongoing stewardship to ensure proper use of diagnostics and medicines, and a hybrid business approach that leverages grants, equity, and debt to finance growth sustainably[3].

Leadership

Aranda is driven by a team with extensive global expertise. Key members include individuals with backgrounds in government, consulting, healthcare, and international development[4]. Notable figures in leadership roles have experience with major companies like Johnson & Johnson and McKinsey & Company, as well as significant roles in public health and governmental transformations[4].

Activities and Impact

While specific activities of Aranda Org Inc. are not detailed in the available information, its overall goal is to address the critical issue of AMR by streamlining the delivery of vital treatments. The organization's method of using a comprehensive and sustainable business model helps bridge the gap between innovation and patient access, particularly in low- and middle-income countries where the need is most pronounced[3].

Note: The information available does not detail Aranda Org Inc. directly; the article is based on Aranda's antimicrobial resistance initiatives.

[1] https://lifeonbelay.org/our_story/ [2] https://lifeonbelay.org/get-involved/ [3] https://aranda.org [4] https://aranda.org/team/ [5] https://meyerfoundation.org/our-people/

More

Poslední diskuze

Nearby

Contact
Aranda Org Inc logo
Aranda Org Inc
+ Follow
4.5
Reviews
New York City
Place
About the organization

- E80 -

Solving the global crisis in antimicrobial resistance The failure of antibiotics is one of the greatest threats we face epidemics driven by multiple pathogens united by increasing resistance to the tools we use to defeat them. Yet investment has declined in both innovation and access to diagnostics and therapeutics. Conventional wisdom calls this market failure. And there is no focus on delivering innovations to patients even though the AMR challenge is greatest in LMICs where the capacity to meet it is at its lowest.

Health (General and Financing)
23 Vacancy More Detail